MKI67 and neoplasm: The anticancer effect of SeHAN is mediated by the suppression of tumour invasion but not proliferation, as indicated by the reduction of matrix metallopeptidase-9 (MMP-9; invasion marker) and the lack of change in Ki-67 level (mitotic marker) [97].